JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
PUT
S&P Global
SPGI
$121B
| $39.9M | 0.01% |
146,200
+11,100
| +8% | +$2.88M |
|
1077
Cirrus Logic
CRUS
$6.11B
| $39.9M | 0.01% |
484,018
-463,896
| -49% | -$31.4M |
|
|
NS
1078
DELISTED
NuStar Energy L.P.
NS
| $39.9M | 0.01% |
1,541,655
+558,647
| +57% | +$15.5M |
|
1079
Mativ Holdings
MATV
$706M
| $39.7M | 0.01% |
945,167
+37,241
| +4% | +$1.55M |
|
1080
Nektar Therapeutics
NKTR
$2.53B
| $39.7M | 0.01% |
122,551
+7,732
| +7% | +$2.24M |
|
1081
Kirby Corp
KEX
$7B
| $39.6M | 0.01% |
442,707
+75,447
| +21% | +$6.25M |
|
1082
Lloyds Banking Group
LYG
$88.8B
| $39.6M | 0.01% |
11,973,240
+632,904
| +6% | +$1.91M |
|
1083
Fox Factory Holding Corp
FOXF
$884M
| $39.6M | 0.01% |
568,692
+17,544
| +3% | +$1.13M |
|
|
MDRX
1084
DELISTED
Veradigm Inc. Common Stock
MDRX
| $39.5M | 0.01% |
4,028,031
-719,926
| -15% | -$7.58M |
|
|
PBCT
1085
DELISTED
People's United Financial Inc
PBCT
| $39.4M | 0.01% |
2,333,511
+974,187
| +72% | +$16M |
|
|
HEWG
1086
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
| $39.1M | 0.01% |
1,349,977
+31,006
| +2% | +$881K |
|
1087
Wheaton Precious Metals
WPM
$60.6B
| $39.1M | 0.01% |
1,313,536
+32,275
| +3% | +$882K |
|
1088
Novartis
NVS
$298B
| $39.1M | 0.01% |
412,610
-221,899
| -35% | -$19.9M |
|
|
ENLC
1089
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $39.1M | 0.01% |
6,373,436
+2,380,974
| +60% | +$14.4M |
|
1090
Norwegian Cruise Line
NCLH
$8.52B
| $39M | 0.01% |
666,976
-218,125
| -25% | -$11.5M |
|
1091
Steel Dynamics
STLD
$38.5B
| $38.9M | 0.01% |
1,143,364
-26,025
| -2% | -$831K |
|
1092
iShares National Muni Bond ETF
MUB
$45.8B
| $38.9M | 0.01% |
341,514
-22,749
| -6% | -$2.59M |
|
1093
Frontline
FRO
$8.56B
| $38.9M | 0.01% |
3,022,584
-547,137
| -15% | -$5.96M |
|
1094
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
| $38.8M | 0.01% |
668,424
-266,309
| -28% | -$15.4M |
|
1095
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
| $38.7M | 0.01% |
282,446
-338,328
| -55% | -$44.8M |
|
1096
Westamerica Bancorp
WABC
$1.35B
| $38.6M | 0.01% |
570,234
-86,912
| -13% | -$5.68M |
|
|
RPAI
1097
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $38.6M | 0.01% |
2,878,358
+430,717
| +18% | +$5.79M |
|
1098
BlackRock Corporate High Yield Fund
HYT
$1.37B
| $38.6M | 0.01% |
3,443,488
+23
| +0% | +$253 |
|
1099
Brown-Forman Class B
BF.B
$12.9B
| $38.5M | 0.01% |
569,639
-122,425
| -18% | -$7.95M |
|
1100
Integer Holdings
ITGR
$4.25B
| $38.5M | 0.01% |
478,499
-97,806
| -17% | -$7.47M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.